Peer Review Committee for Leukemia, Immunology and Blood Cell Development (LIB)

Areas reviewed: Studies dealing with leukemia, lymphomas, other hematologic malignancies and immunology, the hematopoietic system and the control of the development and differentiation of erythroid, myeloid, and lymphoid blood cells. Studies involving platelets, coagulation, the complement system, and the biology of the immune system including cell types, cytokines, antigen processing, antibody molecules, immune tolerance and deficiencies. Preclinical therapeutic studies include chemotherapy, immunotherapeutic approaches and bone marrow transplantation. Related clinical research training grants and clinical research professorships are included. 

Jose Guevara-Patino, MD, Chair
Loyola University, Chicago
Maywood, IL

Ellen Beswick, PhD, Co-Chair
University of New Mexico Health Science Center
Albuquerque, NM

Samita Andreansky, PhD
University of Miami
Miami, FL

Xue-Feng Bai, MD, PhD
Ohio State University
Columbus, OH

Subbarao Bondada, PhD
University of Kentucky
Lexington, KY

Jianjun Chen, PhD
University of Cincinnati
Cincinnati, OH

Stephen Gottschalk, MD
Baylor College of Medicine
Houston, TX

Michael Gough, PhD
Providence Portland Medical Center
Portland, OR

Karen Haas, PhD
Wake Forest University
Winston Salem, NC

Amir Jazaeri, MD
University of Texas MD Anderson Cancer Center
Houston, TX

Amy Johnson, PhD
Ohio State University
Columbus, OH

Kay Kays, Stakeholder
Sun City, AZ

John Ortaldo, PhD
National Institutes of Health
Frederick, MD

Guangyong Peng, MD, PhD
Saint Louis University
Saint Louis, MO

Kathryn Schwertfeger, PhD
The Regents of the University of Minnesota – Twin Cities
Minneapolis, MN

Padmanee Sharma, MD, PhD
University of Texas M.D. Anderson Cancer Center
Houston, TX

Mingjiang Xu, MD, PhD
University of Miami School of Medicine
Miami, FL

Zhenglun Zhu, MD, PhD
Brigham and Women’s Hospital
Boston, MA

Sandra Zinkel, PhD, MD
Vanderbilt University Medical Center
Nashville, TN